Athena Resources Limited (ASX:AHN) Collaborates on Mid West Green Iron Project
Athena Resources (ASX:AHN) partners with Warradarge Energy and Fenix to develop the Mid West Green Iron Project in Western Australia.
Proteomics International Laboratories Ltd (ASX:PIQ) Announces Breakthrough in Equine Muscle Recovery Testing
Proteomics International (ASX:PIQ) unveils the OxiDx test for detecting muscle damage in racehorses, targeting an Australian launch in H2 CY25.
MyEco Group Ltd (ASX:MCO) Announces Q4 FY25 Sales Update
MyEco Group Ltd (ASX:MCO) reports an 8.6% increase in FY25 sales, driven by significant growth in MyEco® products and a strategic operational restructure.
Tungsten Mining NL (ASX:TGN) Advances Mt Mulgine Project with Integrated Gold/Tungsten Strategy
Tungsten Mining NL (ASX:TGN) advances its Mt Mulgine Project with a new integrated gold and tungsten strategy to enhance early cash flow and support long-term development.
G8 Education Limited (ASX:GEM) Responds to ASX Aware Letters
G8 Education Limited (ASX:GEM) addresses ASX’s aware letters concerning an employee charge and subsequent stock price decline.
City Chic Collective Limited (ASX:CCX) Announces FY25 Trading Update
City Chic Collective (ASX:CCX) reports a turnaround to profitability in FY25 with a 2.3% revenue increase and strong growth in ANZ.
Hansen Technologies (ASX:HSN) Raises FY25 EBITDA Guidance
Hansen Technologies (ASX:HSN) upgrades FY25 EBITDA guidance with improved profitability and significant new customer wins.
Abacus Storage King (ASX:ASK) Receives Revised Acquisition Proposal
Abacus Storage King (ASX:ASK) receives a revised non-binding acquisition proposal offering A$1.65 per stapled security.
South32 Limited (ASX:S32) Provides Update on Mozal Aluminium
South32 Limited (ASX:S32) updates on electricity supply challenges for Mozal Aluminium and anticipates impairment expenses in FY25.
Imugene Limited (ASX:IMU) Announces Positive Phase 1b Trial Results for Azer-cel
Imugene Limited (ASX:IMU) reports 75% response rate in Phase 1b trial of azer-cel for relapsed diffuse large B-cell lymphoma.